JNBA Financial Advisors Takes Position in Cerner Co. (CERN)

Share on StockTwits

JNBA Financial Advisors purchased a new position in shares of Cerner Co. (NASDAQ:CERN) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 644 shares of the company’s stock, valued at approximately $34,000.

Other large investors have also recently made changes to their positions in the company. Bank of Montreal Can lifted its holdings in Cerner by 61.2% during the third quarter. Bank of Montreal Can now owns 271,606 shares of the company’s stock valued at $17,493,000 after purchasing an additional 103,122 shares in the last quarter. First Hawaiian Bank purchased a new position in shares of Cerner in the third quarter worth $616,000. Cornerstone Wealth Management LLC lifted its holdings in shares of Cerner by 18.0% in the third quarter. Cornerstone Wealth Management LLC now owns 69,868 shares of the company’s stock worth $978,000 after buying an additional 10,666 shares in the last quarter. IFM Investors Pty Ltd lifted its holdings in shares of Cerner by 14.0% in the third quarter. IFM Investors Pty Ltd now owns 15,652 shares of the company’s stock worth $1,008,000 after buying an additional 1,917 shares in the last quarter. Finally, Calamos Advisors LLC lifted its holdings in shares of Cerner by 6.7% in the third quarter. Calamos Advisors LLC now owns 69,853 shares of the company’s stock worth $4,499,000 after buying an additional 4,412 shares in the last quarter. Institutional investors own 80.49% of the company’s stock.

CERN stock opened at $57.54 on Wednesday. The company has a current ratio of 2.41, a quick ratio of 2.38 and a debt-to-equity ratio of 0.09. Cerner Co. has a twelve month low of $48.78 and a twelve month high of $67.57. The firm has a market cap of $18.78 billion, a price-to-earnings ratio of 26.04, a PEG ratio of 1.92 and a beta of 0.99.

Cerner (NASDAQ:CERN) last posted its quarterly earnings data on Tuesday, February 5th. The company reported $0.63 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.57 by $0.06. Cerner had a net margin of 11.74% and a return on equity of 14.84%. The business had revenue of $1.37 billion for the quarter, compared to analysts’ expectations of $1.39 billion. During the same quarter in the previous year, the business posted $0.58 earnings per share. The business’s revenue was up 3.9% compared to the same quarter last year. As a group, analysts anticipate that Cerner Co. will post 2.37 EPS for the current fiscal year.

CERN has been the topic of several research analyst reports. Barclays lowered their target price on shares of Cerner from $70.00 to $67.00 and set an “equal weight” rating on the stock in a report on Friday, October 26th. Morgan Stanley reduced their price target on shares of Cerner from $72.00 to $68.00 and set an “equal weight” rating on the stock in a research report on Monday, December 3rd. BidaskClub upgraded shares of Cerner from a “sell” rating to a “hold” rating in a research report on Wednesday, January 30th. Zacks Investment Research upgraded shares of Cerner from a “sell” rating to a “hold” rating in a research report on Thursday, November 22nd. Finally, Leerink Swann upgraded shares of Cerner from a “market perform” rating to an “outperform” rating and set a $70.00 price target on the stock in a research report on Monday, October 29th. Nine equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $68.90.

In other Cerner news, Vice Chairman Clifford W. Illig sold 435,000 shares of the business’s stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $57.95, for a total transaction of $25,208,250.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 4.71% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Highlight Press and is the property of of Highlight Press. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://highlightpress.com/2019/02/20/jnba-financial-advisors-takes-position-in-cerner-co-cern.html.

About Cerner

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Featured Article: What is a short straddle?

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.